CE-IVDR Mark for Hologic’s Aptima® HPV Test Expanded to Include Self-Collected Sample Claim in Cervical Cancer Screening

Contributed by: Business Wire

Logo

Images

Hologic’s Aptima® HPV Assay and Aptima Multitest Specimen Collection Kit

Business Wire embedded0

Tags

Oncology

Health

Medical Devices

Consumer

Women

General Health

Biotechnology

CE-IVDR Mark

More Like This

PR Newswire associated0

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public

Home testing kits for lifesaving checks against cervical cancer

PR Newswire associated0

Seegene Unveils HPV Genotyping Solution at EUROGIN 2025

New Survey from Clue Identifies Key Solutions for Increasing Life-Saving Cervical Cancer Screenings

Waiv Achieves Dual CE Marking Under IVDR, Propelling AI Precision Testing for Breast and Colorectal Cancer for Clinical Routine

Fujirebio Europe Expands Its Portfolio With Introduction of the Innovative PreCursor-M AnoGYN assay (RUO) for Methylation Testing in Anal Specimens

PR Newswire associated0

Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024

PR Newswire associated0

Hybribio Calls for Raising International HPV Awareness